Skip to main content

Pharmacy

10:41 am | October 17, 2019
Different states have different methods for identifying 340B drugs billed to programs, findings showed.
By Jeff Lagasse | 12:21 pm | October 15, 2019
The anticipated savings would increase in a scenario in which biosimilars made up a larger portion of the total market share.
By Susan Morse | 10:42 am | October 15, 2019
The bonus pool size in 2018 was $6.3 billion, which goes to 4-star and above plans as $500 per member, per year.
By HIMSS TV | 07:37 am | October 10, 2019
Sunita Patolia, team lead for human-centered design at Partners HealthCare Pivot Labs, says digital health is inherently different from other kinds of innovation like drug trials, and the rules are still being rewritten.
By Jeff Lagasse | 04:09 pm | October 02, 2019
Drugs were administered in a series of surges and lulls that corresponded to changing shifts rather than patient need.
By Susan Morse | 02:45 pm | October 02, 2019
The rule does not have the "vast economic and political significance" put forward by the district court as it would cost drug makers only a fraction of what they pay for TV ads, HHS says in appeal.
By Jeff Lagasse | 04:02 pm | September 23, 2019
Medical providers receiving higher amounts of industry payments tend to bill higher drug and medical costs.
By Jeff Lagasse | 04:06 pm | September 20, 2019
Along with addiction counseling, the drugs naltrexone, buprenorphine and methadone all have a place in treatment for opioid use disorder.
By Susan Morse | 09:48 am | September 20, 2019
The maximum price that could be set is 1.2 times the average international market price.
By Jeff Lagasse | 01:01 pm | September 18, 2019
Not only do commercial payers reimburse clinics at a higher rate than physician offices, but clinics also are eligible for certain discounts.